Elder Pharmaceuticals Ltd

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on May 14, 2013 has decided not to proceed with amalgamation of Elder Health Care Ltd., with the Company.

Elder Pharmaceuticals Limited has informed the Exchange that : "Ratnakar Bank Ltd. have invoked pledge of our Company`s shares and have on 10th and 11th instants sold some of them in the market. This has affected the market price of the shares and the volume also has increased. However, kindly note that neither the promoters nor persons acting in concert have sold any shares in the market".

Elder Pharmaceuticals Limited has informed the Exchange that: "On 10th and 11th instants Ratnakar Bank Ltd. have sold shares of our Company in the market because of which the market price of the shares has come down and volume also has increased. However, kindly note that neither the promoters nor persons acting in concert have sold any shares in the market".

Elder Health Care Limited has submitted to the Exchange, vide letter dated April 23, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Ltd. has submitted to the Exchange vide letter dated April 18, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Health Care Limited has submitted to the Exchange vide its letter dated April 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Health Care Limited has submitted to the Exchange vide letter dated April 08, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Limited has submitted to the Exchange vide letter dated April 04, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shalini Kumar has submitted to the Exchange vide letter dated March 22, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company have decided to extend the Financial Year 2012-13 by three months so as to end on June 30, 2013 instead of March 31, 2013. Accordingly the Company will be preparing its annual accounts for the period of 15 months from April 01, 2012 to June 30, 2013.

Elder Pharmaceuticals Limited has informed the Exchange regarding the Press Release dated March 06, 2013, titled" Elder Pharmaceuticals Limited to Create Joint Venture with KOSE Corporation of Japan".

Shalini Kumar has submitted to the Exchange vide letter dated February 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Ltd has submitted to the Exchange vide letter dated February 26, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt ltd has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Limited has submitted to the Exchange vide letter dated February 20, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Shalini Kumar has submitted to the Exchange vide letter dated February 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals and Chemicals Limited has submitted to the Exchange vide letter dated February 05, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Limited has submitted to the Exchange vide its letter dated January 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Ltd has submitted to the Exchange vide its letter dated January 15, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide its letter dated January 10, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niti Saxena has submitted to the Exchange vide letter dated December 12, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports PVT. Ltd has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niti Saxena has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 05, 2012 titled "Elder Pharmaceuticals Ltd. has received the Certificate of Suitability (cos) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for DIOSMIN API.

Elder Pharmaceuticals Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on September 28, 2012.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 09, 2012 have recommend for consideration of Shareholders declaration of dividend @ 30% i.e. Rs.3/- per share of Rs.10/- each.

Elder Pharmaceuticals Limited has informed the Exchange regarding the outcome of Board Meeting held on August 02, 2012.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated June 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that with reference to the news item "Elder Pharma weighs sale of nutrition business" appearing on various media websites, the Company hereby clarify that the Company has no intentions to sell any business nor is in any discussion with any party. The Company`s Joint Managing Director has already denied in the said news item that the Company was looking to sell any Business.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated March 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for pledge of 25000 shares.

Cholamandalam Investment and Finance Company Limited has submitted to the Exchange vide its letter dated March 22, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt. Ltd. has submitted to the Exchange vide its letter dated March 20, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt. Ltd. has submitted to the Exchange vide its letter dated March 15, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that there was fluctuation in Company`s share price on March 06, 2012 and March 07, 2012. There was an Income Tax Search u/s 132 of Income Tax Act, 1961 on various premises of the Company. However, the said search has hardly yielded anything against the Company.

Elder Pharmaceuticals Limited has informed the Exchange that on February 07, 2012, the Company through its Dubai wholly owned subsidiary has increased the stake in Elder Biomeda AD, Bulgaria from existing 92.2% to 100%.

Indarts Exports Pvt. Ltd . has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Pvt. Ltd. has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the shareholders of the Company held on September 26, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors held on August 12, 2011, following decisions were taken: (1) To hold the Annual General Meeting of the Company on September 26, 2011. (2) To keep the transfer books closed from September 17, 2011 to September 26, 2011 (both days inclusive) for payment of dividend .

Elder Pharmaceuticals Limited has informed the Exchange that the Company`s Whole Time Director, Mr. Alok Saxena is giving an interview on the `CNBC`, TV channel with regards to the Company on June 07, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 10, 2011 amongst others, the following decisions were taken: (1) To form a 50:50 Joint Venture in Guernsey for web marketing of VMS products manufactured by UK and European companies. (2) To approve the appointment of Mr. Madhav Joshi as President -Pharma of the Company.

Elder Pharmaceuticals Limited has informed the Exchange vide its letter dated January 03, 2011 regarding a press release, titled "Elder API Plant gets Japan Ministry of Health Accreditation".

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on December 23, 2010, has approved the allotment of fully paid 1188 of units of Rs. 10,00,000/- each under Secured Redeemable Non Convertible Debenture issue.